Awesome article just got posted on digital journal. See below for cool quotes from the article.
Marc Bookman, Opu Labss CEO said: We want to make sure compliance with our Rule 506(c) offering to accredited investors in the U.S. is watertight. Given Manhattan Street Capitals expertise, it is clear we are in great hands.
Rod Turner, MSCs Chairman & CEO, added: Opu Labs will be one of the major healthcare ICOs for 2018 and we are delighted to be a part of the process. The companys business model is very well thought through and leverages the potential of the blockchain. We are excited to team up with Opu Labs and to support accredited U.S. purchasers participation in this token offering.Manhattan Street Capital is the premier online fundraising platform; helping companies raise IPO capital, and assisting ICOs to become legitimate securities offerings using the correct Regulation A+, Regulation D, and Regulation S processes.
So, US investors can participate in the ICO at this link:
https://www.manhattanstreetcapital.com/opulabs-token-offering-for-us-purchasersSee more:
http://www.digitaljournal.com/pr/3831012#ixzz5JengH3du